Raphael Pharmaceutical Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Raphael Pharmaceutical Inc. reported Cash And Cash Equivalents At Carrying Value of $19.0 thousand for the year ending 2024.

  • Raphael Pharmaceutical Inc. showed a decrease of -91.7% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from Raphael Pharmaceutical Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2020 to 2024), Raphael Pharmaceutical Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 80.0%.
  • Historical annual values: Fiscal year 2024: $19.0 thousand | Fiscal year 2023: $230.0 thousand | Fiscal year 2022: $288.0 thousand | Fiscal year 2021: $153.0 thousand | Fiscal year 2020: $95.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: